CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

Tata India Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
31.74 0.12(0.38%) NAV as on 19 Jun 2026
-0.22 % 1 M
8.28 % 1 Y
21.38 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.15

As on 31 Mar, 2026
age-icon Age :

10 yrs 5 m

Since 28 12 ,2015
exit_load Exit Load :

0.25%

aum AUM :

1,386.99 Crs

lock_in Lock-in :

0.25% on or before 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.31

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Rajat Srivastava

LATEST ASSET & PORTFOLIO ALLOCATION

as on May 31 ,2026
Others 0.70 %
Equity 99.30 %

TOP HOLDINGS

Sun Pharmaceutical Industries...9.38 %
Healthcare Global Enterprises...5.87 %
Divi's Laboratories Ltd.5.80 %
Abbott India Ltd.5.41 %
Cipla Ltd.5.18 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs60.54
Hospital & Healthcare Services30.41
Pesticides & Agrochemicals3.96
Business Support2.65
Household & Personal Products1.35
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)17.1815.8825.0628.6428.10
Net Assets(Rs Crores) (as on 31-Mar-2026) 553.33 493.44 878.70 1183.65 1229.42
Scheme Returns(%)(Absolute)16.04-7.3157.4613.01-0.81
B'mark Returns(%)(Absolute)NANANANANA
Category Rank41/7567/7619/9020/10251/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity31.740.12(0.38%)NAV As on 19 Jun, 202628-Dec-2015Inception Date1,386.99AUM In Cr.8.28%1Y21.38%3Y13.76%5Y11.65%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity41.760.14(0.34%)NAV As on 19 Jun, 202613-Jul-2018Inception Date6,453.52AUM In Cr.8.95%1Y25.61%3Y15.79%5Y19.72%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity476.633.15(0.67%)NAV As on 19 Jun, 202614-Jul-1999Inception Date4,565.95AUM In Cr.14.65%1Y23.76%3Y16.30%5Y16.12%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity42.540.35(0.82%)NAV As on 19 Jun, 202602-Jul-2018Inception Date3,090.51AUM In Cr.14.88%1Y23.58%3Y14.54%5Y19.92%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity33.800.21(0.63%)NAV As on 19 Jun, 202610-Jul-2019Inception Date950.31AUM In Cr.14.15%1Y22.36%3Y13.05%5Y19.16%Since Inception